Atomo Diagnostics Limited (AT1.AX)
Atomo Diagnostics Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Leichhardt, NSW, AU. The stock last traded at $0.02, down 0.00% on the session, giving a market capitalisation of $16.2M. Its beta of 1.10 implies it has historically moved more than the broad market.
Established in 2010 and based in Leichhardt, Australia, Atomo Diagnostics Limited is a global enterprise focused on the innovation and commercialization of medical devices. The company provides swift-result diagnostic tools designed for various applications, including COVID-19 detection, HIV screening, pregnancy confirmation, and assessing respiratory conditions.
Atomo Diagnostics Limited is most often compared with the following Healthcare names: